Related Experiment Video
Updated: Apr 21, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Evaluating oral nutritional support and the nutritional risk scores in ICI-treated metastatic solid tumours
Caner Acar1, Gökhan Şahin1, Haydar Çağatay Yüksel1
1Division of Medical Oncology, Departmant of Internal Medicine, Ege University Medical Faculty, Izmir, Turkey.
Background:
Malnutrition is common in metastatic cancer and may compromise outcomes. We evaluated whether oral nutritional supplementation (ONS) improves survival and compared the performance of nutritional risk scores in immune checkpoint inhibitor (ICI)-treated patients.
Methods:
We retrospectively analyzed 538 adults with metastatic solid tumors who initiated ICIs between 2015 and 2024. Baseline ONS use, clinicopathological variables, and laboratory parameters were recorded. Survival outcomes were assessed after 1:1 propensity score matching (PSM).
Results:
246 matched patients were evaluated. ONS was not associated with better overall survival (OS: median 13.9 vs 11.0 months; p = 0.70) or progression-free survival (PFS: 3.4 vs 4.4 months; p = 0.11). Immune-related adverse events (irAEs) occurred in 40.2% of ONS users versus 34.0% of non-users (p = 0.469). The Geriatric Nutritional Risk Index (GNRI), Prognostic Nutritional Index (PNI), Controlling Nutritional Status (CONUT) score, and modified Glasgow Prognostic Score (mGPS) independently predicted OS and PFS (all p < 0.001), with PNI and mGPS showing the best discrimination. Subgroup analyses across nutritional scores revealed no survival benefit with ONS.
Conclusions:
ONS did not improve survival or rates of irAEs in metastatic patients receiving ICIs, whereas nutritional scores provided strong prognostic stratification. Prospective trials integrating longitudinal nutrition monitoring, immunonutrition, and multimodal cachexia therapy are warranted.
Related Concept Videos
Tumor Immunotherapy
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Treatment Resistant Cancers